US FDA approves Scholar Rock's muscle weakness drug
SRRK•FDA approves Scholar Rock therapy for rare genetic condition
Sept. 11 (Reuters) - The U.S. Food and Drug Administration on Friday approved Scholar Rock's SRRK.O therapy to treat a rare genetic condition that causes muscle weakness.
